Skip to main content

TPG — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

109
Companies
$126.9B
Total invested
$1.8B
Avg. check
55
Industries
Biotechnology 8Health Care 8Therapeutics 4SaaS 3Information Technology 3Artificial Intelligence (AI) 3+49 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 4972 of 109
Zenefits
October 2021

Zenefits delivers a complete, all-mobile HR experience for small and medium businesses.

Health Insurance · San FranciscoVenture - Series Unknown
Enpal
October 2025

Enpal is a photovoltaics leasing firm that provides solar power systems for homeowners.

Energy · Berlin$812.0M Debt Financing
Trumid
October 2021

Trumid is a financial technology company and fixed income electronic trading platform.

Banking · New York$208.0M Private Equity
AirTrunk
March 2026

AirTrunk develops and operates wholesale hyperscale data center solutions within the technology sector.

Data Center · North Sydney$1.2B Debt Financing
OpenAI
February 2026

OpenAI is an AI research and deployment company that develops advanced AI models, including ChatGPT.

Agentic AI · San Francisco$110.0B Corporate Round
Bicara Therapeutics
February 2026

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Biopharma · Cambridge$150.0M Post Ipo Equity
Vaxcyte
January 2026

Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.

Biopharma · San Carlos$632.5M Post Ipo Equity
HyperVault AI Data Center
November 2025

HyperVault AI Data Center enable to provide multiple AI and Sovereign Data Centers for providing IT enable services.

Artificial Intelligence (AI) · Mumbai$1.0B Private Equity
Saluda Medical
November 2025

Saluda Medical is a commercial-stage medical device company that develops treatments for chronic neurological conditions.

Health Care · Bloomington$30.0M Undisclosed
Ultragenyx Pharmaceutical
November 2025

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

Biotechnology · Novato$400.0M Post Ipo Debt
Odyssey Therapeutics
September 2025

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

Biotechnology · Cambridge$213.0M Series D
NIO
September 2025

NIO is an automotive company that designs and develops electric autonomous vehicles.

Automotive · Shanghai$1.2B Post Ipo Equity
Evolent Health
August 2025

Evolent Health specializes in delivering clinical and administrative solutions.

Health Care · Arlington$145.0M Post Ipo Debt
Daybreak
June 2025

Daybreak is an enterprise AI company that offers an AI-native platform for supply chain planning and decision automation.

Analytics · San Francisco$15.0M Series A
Twelve
May 2025

Twelve is a carbon transformation company converting captured carbon dioxide into valuable chemicals, fuels, and other essential products.

Carbon Capture · BerkeleySeries Unknown
DealStack
April 2025

Helping Private Equity dealmaking evolve.

London$5.5M Seed
Shadowfax Technologies Limited
March 2025

Shadowfax - India's Trusted Partner For Speed and Reliable Delivery

Courier Service · Bangalore$3.0M Series Unknown
Ouro Medicines
January 2025

Ouroboros Medicines is a biotechnology company specializes in immunology.

Biotechnology · San Francisco$120.0M Series A
Intersect Power
December 2024

Intersect Power develops and operates clean energy infrastructure and power generation projects that serve customers in energy markets.

Energy · Beaverton$800.0M Private Equity
ADCendo
November 2024

ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs.

Biotechnology · Copenhagen$135.0M Series B
Hybar
September 2024

Hybar builds and operates a scrap metal recycling steel rebar production facility.

Industrial · OsceolaCorporate Round
Santa Ana Bio
June 2024

Santa Ana Bio is a biotechnology company focusing on precision immunology for autoimmune and inflammatory diseases.

Biotechnology · Alameda$125.0M Series B
Allogene Therapeutics
May 2024

Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.

Biotechnology · South San Francisco$110.0M Post Ipo Equity
Sayari Labs
April 2024

Sayari Labs is a provider of financial intelligence and supply chain risk solutions for analysts and investigators.

Analytics · Washington$235.0M Private Equity

Where TPG invests

Biotechnology8
Health Care8
Therapeutics4
SaaS3
Information Technology3
Artificial Intelligence (AI)3

About TPG's portfolio

How many companies has TPG invested in?

TPG has invested in 109 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does TPG invest in?

TPG's top investment sectors include Biotechnology, Health Care, Therapeutics, SaaS, Information Technology. The firm invests across 55 different industry categories.

What is TPG's largest investment?

Among tracked funding rounds, OpenAI received $110.0B in a Corporate Round round. TPG's total known invested capital is $126.9B.

What is the average investment size for TPG?

TPG's average investment size is $1.8B across its portfolio of 109 companies.

What are TPG's most recent investments?

Recent TPG portfolio additions include Zenefits, Enpal, Trumid, AirTrunk, OpenAI. These companies were founded in 2020 or later.

Reach the founders behind these 109 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →